Title of Invention

OXYGEN SCAVENGING COMPOSITION AND METHOD FOR MAKING SAME

Abstract There is provided a polymeric composition for scavenging oxygen comprising a polymer; and a hydrogenated anthraquinone derivative and/or its enol/enolate tautomer or a substituted derivative thereof; wherein the polymer is selected from the group comprising EVOH, polyamide, polyester, polyethylene, polyvinyl alcohol, a polymer comprising metaxylene diamine and adipic acid units, or a polymer comprising terephthalic acid and ethylene glycol units and blends thereof; and wherein the hydrogenated anthraquinone derivative is selected from one or more compounds represented by the following formulae and substituted derivatives thereof: According to the invention there is also provided a method of scavenging oxygen in an atmosphere or liquid comprising the steps of:(i) providing a polymeric composition as claimed in any one of claims 1 to 15; and (ii) exposing the atmosphere or liquid to the composition; such that at least a portion of the oxygen in the atmosphere or liquid is removed through oxidation of the hydrogenated anthraquinone derivative and/or its enol/enolate tautomer.There is also provided a method of preventing the transmission of oxygen through a package.
Full Text

OXYGEN SCAVENGING COMPOSITION AND METHOD FOR MAKING SAME
FIELD OF THE INVENTION
This invention relates to a method of scavenging oxygen using polymeric compositions
comprising hydrogenated anthraquinone derivatives, for use in, for example, Food and
beverage packaging to scavenge unwanted oxygen,which either remains within the package,
or otherwise enters the package, following the packaging of the food or beverage. The
hydrogenated anthraquinone derivative may also be incorporated into packaging materials, to
scavenge oxygen which would otherwise have permeated through the packaging material to
enter the inside of a package.
BACKGROUND OF THE INVENTION
A wide variety of foods, beverages, pharmaceuticals and other materials are susceptible to
significant loss in quality if they are exposed to oxygen during storage. The damage can arise
from, for example, chemical oxidation of the product and/or microbial growth. In the field of
packaging, such damage has been traditionally addressed by generating relatively low-oxygen
atmospheres by vacuum packing and/or inert gas flushing. However, these methods are not
generally applicable for various reasons. For example, the fast filling speeds commonly used
in the food and beverage industries often prevent effective evacuation of, or thorough inert
gas flushing of, food and beverage packages, and neither evacuation or inert gas flushing
provides any residual capacity for removal of oxygen which may have desorbed from the
package contents or entered the package by leakage or permeation. As a consequence, there
has been much Interest in the identification and development of chemical techniques for
generating low-oxygen atmospheres.
In Australian Patent No. 672661 (the entire disclosure of which is incorporated herein by
reference), the present applicant describes novel oxygen scavenging compositions comprising
a source of labile hydrogen or electrons and a reducible organic compound, which may be
readily activated or "triggered" (ie brought to its oxygen scavenging form) as required by
exposure to, for example, ultraviolet (UV) light. The oxygen scavenging compositions, once

activated, are capable of scavenging oxygen from an oxygenated atmosphere or liquid in
substantial darkness for periods ranging from up to a few minutes or hours to over 100 days.
Most of the exemplified oxygen scavenging compositions described in Australian Patent No.
672661, arc based on substituted anthraquinones as the reducible organic compound. Further
examples of substituted anthraquinones suitable for use as the reducible organic compound in
such oxygen scavenging compositions are disclosed in International Patent Application No.
PCT/AU02/00341 (WO 02/076916) (the entire disclosure of which is hereby incorporated by
reference).
There is a general need for alternative compounds and compositions useful for scavenging
oxygen and, in particular, there is a need for compounds and compositions which do not
necessarily require activation subsequent to formation into packaging materials in order to
scavenge oxygen.
In addition, the substituted anthraquinones of the prior art discussed above tend to be coloured
particularly in the reduced states. Compositions and packaging which contain such anthraquinones also tend to be coloured. For instance, films made using anthraquinone-based
compositions can turn a deep yellow colour when the anthraquinone is reduced to activate the
oxygen scavenging capacity. The coloured nature of the anthraquinone-based compositions is
undesirable in many forms of packaging, particularly in the packaging of foodstuffs. It is
therefore desirable, although not essential, that any alternative compounds and compositions
for scavenging oxygen have, in general, substantially less colour than the prior art substituted
anthraquinones.
SUMMARY OF THE INVENTION
In a first aspect, the present invention provides a polymeric composition comprising a
hydrogenaled anthraquinone derivative and/or its enol/enolate tautomer or a substituted
derivative thereof.

In a second aspect, the present invention provides a method of scavenging oxygen
(particularly ground stale molecular oxygen) in an atmosphere or liquid comprising the steps
of:
(i) providing a polymeric composition according to the first aspect; end
(ii) exposing the atmosphere or liquid to the composition;
such that at least a portion of the oxygen in the atmosphere or liquid is removed through
oxidation of the bydrogenated anthraquinone derivative and/or its enol/enolate tautomer.
In a third aspect, the present invention provides a method of preventing the transmission of oxygen (particularly ground slate molecular oxygen) through a package, said method
comprising forming a package comprising or consisting of a packaging material, said
packaging material comprising a polymeric composition according to the first aspect.
BRIEF DESCRIPTION OF THE ACCOMPANYING FIGURES
Figure 1 shows a graph of oxygen transmission over time for EVOH films incorporating 2-
Me-THAQ, and EVOH films not incorporating 2-Me-THAQ.
Figure 2 shows a graph of oxygen transmission over time for MXD6 films incorporating
THAQ, and MXD6 films not incorporating THAQ.
Figure 3 shows UV-visible absorption spectra for THAQ in (a) isopropanol and (b) DMSO.
Figure 4 shows a UV visible absorption spectrum for THAQ in MXD6 film.
Figure 5 shows a UV-visible absorption spectrum for 2-Me-THAQ in EVOH film.
Figure 6 shows the UV-visible absorption spectra for (a) THAQ (b) 2-Me-THAQ, and (c) 2-
Me-HHAQ in PETG.

DETAILED DESCRIPTION OF THE INVENTION
Hydrogenated anthraquinone derivatives, when in neat solid form, do not in general
observably react with oxygen. The present applicant has surprisingly found that polymeric
films formed by melt compression of hydrogenated anthraquinone derivatives with a range of
different commercially available polymers, including ethylene-vinyl alcohol copolymers
(EVOH) and polymers comprising metaxylcnc diamine and adipic acid (eg MXD-6 nylon),
absorb oxygen. The films do not require activation subsequent to processing in order to
scavenge oxygen.
As can be seen from the Examples, the absorption spectra of the polymeric films comprising
THAQ indicates that a different chemical derivative is present in the film. The present
applicant believes that this chemical derivative is the enol/enolate tautomer of THAQ.
Without being bound by theory, it is believed that the presence of a base, present in residual
amounts in some commercially available polymers, can catalyse the formation of the
enol/enolate tautomer of the hydrogenated anthraquinone derivative and it is this species that
absorbs (ic scavenges) the oxygen. Acid is also known to catalyse the tautomerisation of
hydrogenated anthraquinones to the enol/enolate forms. It is also possible that the efficiency
of the formation of the enol/enolate tautomer is related to the polarity of the polymer and/or
the temperature involved in forming the polymeric composition.
Accordingly, in a first aspect, the present invention provides a polymeric composition
comprising a hydrogenated anthraquinone derivative and/or its enol/enolate tautomer or a
substituted derivative thereof.
The hydrogenated anthraquinone derivative and/or its enol/enolate tautomer is preferably
selected from a compound of one of the formulae I, II and III:


wherein each R is independently selected from hydrogen, a positively charged ion, an ester
linkage and an either linkage and wherein the bonds in rings A and C of the hydrogenated
anthraquinone derivative and/or its enol/enolate tautomer can be independently saturated or
unsaturated and the hydrogenated anthraquinone derivative and/or its enol/enolate tautomer is
optionally substituted.
More preferably, the hydrogenated anthraquinone derivative and/or its enol/enolate tautomer
is preferably selected from a compound of one of the formulae IV, V and VI:

wherein each R is independently selected from hydrogen, a positively charged ion, an ester
linkage and an ether linkage and wherein the bonds in ring C of the hydrogenated
anthraquinone derivative and/or its enol/enolate tautomer can be independently saturated or
unsaturated and the hydrogenated anthraquinone derivative and/or its enol/enolate tautomer is
optionally substituted.
Preferably, the positively charged ion is Na1.
More preferably, the hydrogenated anthraquinone derivative comprises one or more
compounds represented by the following formulae and substituted derivatives thereof:


Particularly preferred hydrogenated anthraquinone derivatives are 1,4,4a,9a-
Tetrahydroanihraquinonc (THAQ) and substituted derivatives thereof. Preferred substituents
arc alkyl (particularly C1-6 alkyl), halo, carboxylic acid, ester, anhydride, epoxy, hydroxy, and
amine groups. An example of a substituted derivative is 2-methyl-1,4,4a,9a-
Tctrahydroanthraquinone (2-Me-THAQ).
The present applicant expects, in the light of their discovery, that the direct incorporation into
a polymeric composition of the enol/enolate form of a hydrogenated anthraquinonc derivative
would also result in a polymeric composition capable of scavenging oxygen.
Accordingly, in a preferred embodiment, the hydrogenated anthraquinone derivative and/or its
enol/enolate derivative is an enol/enolate tautomer of a hydrogenated anthraquinone
derivative or a substituted derivative thereof.
Preferably, the enol/enolate tautomer of a hydrogenated anthraquinone derivative is selected
from a compound of one of the formulas VII and VIII and substituted derivatives thereof:

wherein each R is independently selected from hydrogen, a positively charged ion, an ester
linkage and an either linkage. More preferably, both of the R groups are hydrogen or ester
linkages.

A preferred positively charged ion is Na+.
Preferably, the compound is of formula VII. More preferably, the enol/enolate tautomer of a
hydrogenated antriraquinone deri vative is the di sodium salt of formula VII.
Preferably, the polymeric composition of the first aspect further comprises an acid or base.
The amount of acid or base that may be present is preferably in the range of from 0.05% to
1.0% and more preferably in the range of 0.05% to 0.1 % by weight of the polymeric
composition.
The person skilled in the art would be aware of a number of acids that would be suitable to be
incorporated in any particular polymer composition according to the present invention.
Suitable acids include organic and inorganic acids such as hydrochloric acid, benzoic acid, p-
toluencsulphonic acid, and acidic salts such as sodium chloride, potassium sulphate and
ammonium chloride.
The person skilled in the art would be aware of a number of bases that would be suitable to be
incorporated in any particular polymer composition of the present invention. Suitable bases
include inorganic bases such as sodium hydroxide and basic salts such as, metal salts of
carboxylates, carbonates and bicarbonates.
Polymeric compositions of the first aspect may be in a solid, semi-solid (eg a gel) or liquid
(eg a polymeric liquid such as an ink) form. They may therefore be applied as, or
incorporated in, for example, bottle closure liners, inks, coatings, adhesives (eg
polyurethanes), films, sheets, or layers in containers such as trays, bottles or blister packaging
either alone or as laminations or co-extrusions. When used in films or layers, they may be
blended with typical polymers or copolymers used for construction of films or layers such as
those approved for food or pharmaceutical contact. Such films or layers may be produced by extrusion at temperatures between 50 "C and 350 °C depending upon chemical composition and molecular weight distribution.
The hydrogenated anthraquinone derivative may be blended into the polymeric composition.
The polymeric composition may be formed from any suitable polymer or blend of polymers

including polyamides,.polyesters, polyethylene and polyvinyl alcohols. Preferably, the
polymer is EVOH, a polymer comprising metaxylene diamine and adipic acid units (eg
MXD-6), or a polymer comprising terephthalic acid and ethylene glycol units (eg PET).
Alternatively, or additionally, the hydrogenated anthraquinone derivative itself may be in a
polymerised form either as homopolymcrs or copolymers. Oligomer forms may also be
suitable. Hydrogenated anthraquinone derivative-based monomers can be made, for example,
by covalently bonding an ethylenically unsaturated group to ring A or C of the hydrogenated
anthraquinone derivative. The hydrogenated anthraquinone derivative may also comprise
groups, such as carboxylic acid, ester, anhydride, epoxy, hydroxy, and amine groups, capable
of reaction with other polymerisable molecules and preformed polymers including reactions,
involving the hydroxy groups of the enol tautomer. For instance, it is contemplated by the
present applicant that an enol/enolate tautomer of formula VII3 can effectively act as a
monomer in a copolymer by bridging through the two alcohol substituents via formation of
ester or ether linkages.
The polymeric compositions of the first aspect arc able to scavenge oxygen independently of
the presence of a transition metal catalyst. Accordingly, in a preferred embodiment, the
polymeric compositions do not comprise a transition metal catalyst.
Preferably, the hydrogenated anthraquinone derivatives and/or their enol/enolate tautomer for
use in the method of the present invention are substantially colourless or show reduced colour
relative to anthraquinones (particularly 2-ethylanthraquinone). Preferably, the hydrogenated
anthraquinone derivative and/or its enol/enolate tautomer is selected such that it has a
maximum absorbance in the visible spectrum (400nm - 700nm) that is no more than half that
of the reduced form of 2-ethylanthraquinone in EVOH under the same conditions.
In a second aspect, the present invention provides a method of scavenging oxygen
(particularly ground state molecular oxygen) in an atmosphere or liquid comprising the steps
of:
(i) providing a polymeric composition according to the first aspect; and

(ii) exposing the atmosphere or liquid to the composition;
such that at least a portion of the oxygen in the atmosphere or liquid is removed through
oxidation of the hydrogenated anthraquinone derivative and/or its enol/enolate tautomcr.
The person skilled in the art would be aware that polymeric compositions of the first aspect
may also be used as a chemical barrier to oxygen transmission through a packaging material.
Thus, if a packaging material has Finite oxygen permeability, the oxygen passing through it
from the outside environment can be scavenged by the hydrogenated anthraquinone or
cnol/enolate tautomer thereof.
Accordingly, in a third aspect, the present invention provides a method of preventing the
transmission of oxygen (particularly ground state molecular oxygen) through a package, said
method comprising forming a package comprising or consisting of a packaging material, said
packaging material comprising a polymerie composition according to the first aspect.
In order that the nature of the present invention may be more clearly understood, preferred
forms thereof will now be described with reference to the following non-limiting examples.


EXAMPLES
Example 1: Oxygen scavenging by a composition comprising THAQ in EVOH
A composition was prepared by blending l,4,4a,9a-Tetrahydroanthraquinone (THAQ) at a
level of approximately 2%w/w into commercially available EVOH (32 mole% ethylene
content) at 190 "C. The composition was then compression moulded to form a film having a
thickness of about 30 µm. The film was then quickly transferred into a foil multilayer bag,
and this bag was then vacuum-sealed to form a flat package containing essentially no
hcadspacc. This foil-lined pouch allows essentially no ingress of oxygen from the atmosphere
into the inside of the pouch. Air was then injected into the foil-lined pouch and the pouch
stored at constant temperature. The oxygen content inside the pouch was determined using
gas chromatography. The change in oxygen concentration in three pouches prepared in the
manner described above, and stored at 40 °C, is shown in Table 1. The films were
substantially colourless and remained that way after exposure to oxygen.


Example 2: Oxygen scavenging by a composition comprising 2-Me-THAQ in EVOH
The composition was prepared by blending 2-TncthyI-l,4,4a,9a-Tetrahydroanthraquinone (2-
Me-THAQ) at a level of approximately 2%w/w into EVOH (44 molc% ethylene content) at
190 oC. The composition was then compression moulded at 190 °C to form films having a
thickness of about 50 µm. Each film was then quickly transferred into a foil multilayer bag,
and the hags were then vacuum-sealed to form flat packages containing essentially no
headspace. This Foil-lined pouch allows essentially no ingress of oxygen from the atmosphere
into the inside of the pouch. A 4% O2/96% N2 gas mixture was then injected into each pouch.
The pouches were then placed in a 120 *C oven to simulate the temperature of retort
processing. The oxygen concentration of the headspace was determined using Gas
Chromatography. The change in oxygen concentration in the pouches prepared in the manner
described above is shown in Table 2. The films were substantially colourless and remained
that way after exposure to oxygen.


Example 3: Enhanced barrier to oxygen permeation by a composition comprising 2-Me-
THAQ in EVOH
EVOH films (44 mole% ethylene content) containing approximately 2%w/w 2-Me-TILAQ
were prepared by melt-mixing and then melt-compression at 190 oC. Film thicknesses were
in the range 40-60 µm, and care was required to prepare films free from entrapped air bubbles
which would otherwise interfere with the measurements. The oxygen transmission
measurements were conducted using a technique involving sandwiching an oxygen-sensitive
indicator film containing rubrene between two EVOH-based test films and sealing the three
layers in a test cell. The test cell is then placed in an illuminated controlled
temperature/humidity cabinet. The tests in this work were performed in air at 23 °C and 57%
RH. The colour of the oxygen-sensitive indicator film decreases in the presence of oxygen
and light, and this change is used to determine the permeation Tate of oxygen through the test
films. The light in the storage cabinet was filtered such that only the rubrene in the oxygen-
sensitive indicator film received light during the course of experiments. The results of the
experiments are shown in Figure 1 and they clearly indicate that the incorporation of 2-Mc-
THAQ into the EVOH film substantially reduces the amount of oxygen transmitted through
the film. The films were substantially colourless and remained that way after exposure to
oxygen.
Example 4: Enhanced barrier to oxygen permeation by a composition comprising
THAQ in MXD6
The amorphous MXD6 films containing approximately 2%w/w THAQ were prepared by
melt-mixing and then melt-compression at 250 oC. Film thicknesses were in the range 50-70
µm, and care was required to prepare films free from entrapped air bubbles which would
otherwise interfere with the measurements. The oxygen transmission measurements were conducted using a technique involving sandwiching an oxygen-sensitive indicator film
containing rubrene between two MXD6-based test films and sealing the three layers in a test
cell. The test cell is then placed in an illuminated controlled temperature/humidity cabinet.
The tests in this work were performed in air at 23 °C and 57% RH. The colour of the oxygen-
sensitive indicator film decreases in the presence of oxygen and light, and this change is used

to determine the permeation of oxygen through the test films. The light in the storage cabinet
was filtered such that only the rubrene in the oxygen-sensitive indicator film received light
during the course of experiments. Figure 2 indicates that oxygen transmission through the
MXD6 film is reduced substantially when the film comprises THAQ, The films were
substantially colourless and remained that way after exposure to oxygen.
Example 5: Enolisation of THAQ in solution
The absorption spectrum of a solution of THAQ dissolved in isopropanol (libelled "a") and a
solution of THAQ dissolved in DMSO (labelled "b") is shown in Figure 3. The difference
between the absorption spectrum for THAQ in isopropanol and THAQ in DMSO indicates
the formation of a different chemical species in DMSO, and the identity of this species was
determined by 1H nmr analysis to be the enol form of THAQ. Enolisation of THAQ was
found not to occur in isopropanol solution at room temperature.
Example 6: Enolisation of THAQ in MXD6
The composition was prepared by blending approximately 2%w/w of THAQ into
commercially available MXD6, followed by compression moulding at 250 °C to form a film
having a thickness of about 50 urn. The absorption spectrum of this film is shown in Figure
4. The difference between the absorption spectrum of THAQ in isopropanol (see Figure 3,
spectrum "a") and THAQ in MXD6 indicates the formation of a different chemical species in
the MXD6, and this new species is assigned to the enol form of THAQ due to the very close
similarity to the absorption spectrum of the enol tautomcr in DMSO shown in Figure 3,
spectrum "b".
Example 7: Enolisation of 2-Me-THAQ in EVOH
A composition was prepared by blending 2-Me-THAQ at a level of approximately l%w/w
into commercially available EVOH (44 mole% ethylene content) at 190 oC. The composition
was then compression moulded to form a film having a thickness of about 75 µm. The
absorption spectrum of this film is shown in Figure 5. The difference between the absorption
spectrum of THAQ in isopropanol (sec Figure 3T spectrum "a") and 2-Me-THAQ in EVOH

indicates the formation of a different chemical species in the EVOH, and this new species is
assigned to the cnol form of 2-McTHAQ due to the very close similarity to the absorption
spectrum of the enol tautomer of THAQ in DMSO shown in Figure 3, spectrum "b".
Example 8: Enolisation of hydrogenated anthraquinone derivatives in PETG
Compositions were prepared by blending THAQ, 2-Me-THAQ and 2-Me-1 ,2,3,,4,4a,9a-
Hexahydroanthraquinone (2-Me-HHAQ) at a level of approximately l%w/w into
commercially available PETG at 190 °C. The compositions were then compression moulded
to form films having a thickness of about 110 µm. The absorption spectra of these films are
shown in Figure 6. The difference between the absorption spectrum of THAQ in isopropanol
(see Figure 3, spectrum "a") and these hydrogenated anthraquinone derivatives in PETG
indicates the formation of a different chemical species in the PETG, and this new species is
assigned to the enol forms of the hydrogenated anthraquinone derivatives due to the close
similarity to the absorption spectrum or the enol tautomer of THAQ in DMSO shown in
Figure 3, spectrum "b".
Throughout this specification the word "comprise", or variations such as "comprises" or
"comprising", will be understood lo imply the inclusion of a stated element, integer or step, or
group of elements, integers or steps, but not the exclusion of any other element, integer or
step, or group of elements, integers or steps.
All publications mentioned in this specification are herein incorporated by reference. Any
discussion of documents, acts, materials, devices, articles or the like which has been included
in the present specification is solely for the purpose of providing a context for the present
invention. It is not to be taken as an admission that any or all of these matters form part of the
prior art base or were common general knowledge in the field relevant to the present
invention as it existed in Australia or elsewhere before the priority date of each claim of this
application.
It will be appreciated by persons skilled in the art that numerous variations and/or
modifications may be made to the invention as shown in the specific embodiments without

departing from the spirit or scope of the invention as broadly described. The present
embodiments are, therefore, to be considered in all respects as illustrative and not restrictive.

We claim:
1.. A polymeric composition for scavenging oxygen comprising
a polymer; and
a hydrogenated anthraquinone derivative and/or its enol/enolate tautomer
or a substituted derivative thereof;
wherein the polymer is selected from the group comprising EVOH,
polyamide, polyester, polyethylene, polyvinyl alcohol, a polymer comprising
metaxylene diamine and adipic acid units, or a polymer comprising terephthalic
acid and ethylene glycol units and blends thereof; and
wherein the hydrogenated anthraquinone derivative is selected from one
or more compounds represented by the following formulae and substituted
derivatives thereof:

2. A polymeric composition as claimed in claim 1, wherein the hydrogenated
anthraquinone derivative is l,4,4a,9a-Tetrahydroanthraquinone or a substituted
derivative thereof.
3. A polymeric composition as claimed in claim 1 or 2, wherein the hydrogenated
anthraquinone derivative and/or its enol/enolate derivative is an enol/enolate
tautomer of a hydrogenated anthraquinone derivative or a substituted derivative
thereof.
4. A polymeric composition as claimed in claim 1, wherein the enol/enolate
tautomer of a hydrogenated anthraquinone derivative is selected from a
compound of one of the formulas VII and VIII and substituted derivatives
thereof:

wherein each R is independently selected from hydrogen, a positively
charged ion, an ester linkage and an ether linkage, such as herein described.
5. A polymeric composition as claimed in claim 4, wherein the enol/enolate
tautomer of a hydrogenated anthraquinone derivative is a compound of formula
VII or a substituted derivative thereof.

6. A polymeric composition as claimed in claim 5, wherein the compound of
formula VII is the disodium salt of formula VII.
7. A polymeric composition as claimed in any one of claims 1 to 6, containing an
acid.
8. A polymeric composition as claimed in claim 7, wherein the amount of acid
present is in the range of from 0.05% to 1.0% by weight of the polymeric
composition.
9. A polymeric composition as claimed in claim 9, wherein the amount of acid
present is in the range of 0.05% to 0.1% by weight of the polymeric
composition.
10. A polymeric composition as claimed in any one of claims 1 to 6, containing a
base.
11. A polymeric composition as claimed in claim 10, wherein the amount of base
present is in the range of from 0.05% to 1.0% by weight of the polymeric
composition.
12. A polymeric composition as claimed in claim 8, wherein the amount of base
present is in the range of 0.05% to 0.1% by weight of the polymeric
composition.
13. A polymeric composition as claimed in any one of claims 7 to 9, wherein the
acid is selected from the group consisting of hydrochloric acid, benzoic acid, p- toluenesulphonic acid, sodium chloride, potassium sulphate and ammonium chloride.
14. A polymeric composition as claimed in any one of claims 10 to 12, wherein the
base is selected from sodium hydroxide and metal salts of carboxylates,
carbonates and bicarbonates.
15. A polymeric composition as claimed in any one of claims 1 to 14, wherein the
polymeric composition does not comprise a transition metal catalyst.
16. A packaging material comprising a polymeric composition as claimed in any
one of claims 1 to 15.
17. A method of scavenging oxygen in an atmosphere or liquid comprising the steps
of:
(i) providing a polymeric composition as claimed in any one of claims 1 to
15; and
(ii) exposing the atmosphere or liquid to the composition; such that
at least a portion of the oxygen in the atmosphere or liquid is removed
through oxidation of the hydrogenated anthraquinone derivative and/or
its enol/enolate tautomer.

18. A method of preventing the transmission of oxygen through a package, said
method comprising forming a package comprising or consisting of a packaging
material, said packaging material comprising a polymeric composition as
claimed in any one of claims 1 to 15.



ABSTRACT


OXYZEN SCAVENGING COMPOSITION AND METHOD FOR MAKING SAME
There is provided a polymeric composition for scavenging oxygen comprising a polymer; and a
hydrogenated anthraquinone derivative and/or its enol/enolate tautomer or a substituted derivative
thereof; wherein the polymer is selected from the group comprising EVOH, polyamide, polyester,
polyethylene, polyvinyl alcohol, a polymer comprising metaxylene diamine and adipic acid units, or a
polymer comprising terephthalic acid and ethylene glycol units and blends thereof; and wherein the
hydrogenated anthraquinone derivative is selected from one or more compounds represented by the
following formulae and substituted derivatives thereof:

According to the invention there is also provided a method of scavenging oxygen in an atmosphere or
liquid comprising the steps of:(i) providing a polymeric composition as claimed in any one of claims
1 to 15; and (ii) exposing the atmosphere or liquid to the composition; such that at least a portion of the
oxygen in the atmosphere or liquid is removed through oxidation of the hydrogenated anthraquinone
derivative and/or its enol/enolate tautomer.There is also provided a method of preventing the
transmission of oxygen through a package.

Documents:

03832-kolnp-2006 abstract.pdf

03832-kolnp-2006 claims.pdf

03832-kolnp-2006 correspondence others.pdf

03832-kolnp-2006 description (complete).pdf

03832-kolnp-2006 drawings.pdf

03832-kolnp-2006 form-1.pdf

03832-kolnp-2006 form-3.pdf

03832-kolnp-2006 form-5.pdf

03832-kolnp-2006 g.p.a.pdf

03832-kolnp-2006 international publication.pdf

03832-kolnp-2006 international search report.pdf

03832-kolnp-2006 pct others.pdf

03832-kolnp-2006 priority document.pdf

03832-kolnp-2006-assignment.pdf

03832-kolnp-2006-correspondence-1.1.pdf

03832-kolnp-2006-others.pdf

3832-KOLNP-2006-(18-09-2012)-CORRESPONDENCE.pdf

3832-KOLNP-2006-(21-05-2012)-CORRESPONDENCE.pdf

3832-KOLNP-2006-ABSTRACT 1.1.pdf

3832-KOLNP-2006-ABSTRACT-1.2.pdf

3832-KOLNP-2006-AMANDED CLAIMS-1.1.pdf

3832-KOLNP-2006-AMANDED CLAIMS.pdf

3832-KOLNP-2006-AMANDED PAGES OF SPECIFICATION.pdf

3832-KOLNP-2006-ASSIGNMENT.pdf

3832-KOLNP-2006-CANCELLED PAGES.pdf

3832-KOLNP-2006-CORRESPONDENCE-1.1.pdf

3832-KOLNP-2006-CORRESPONDENCE.pdf

3832-KOLNP-2006-DESCRIPTION (COMPLETE) 1.1.pdf

3832-KOLNP-2006-DESCRIPTION (COMPLETE)-1.2.pdf

3832-KOLNP-2006-DRAWINGS 1.1.pdf

3832-KOLNP-2006-DRAWINGS-1.2.pdf

3832-KOLNP-2006-EXAMINATION REPORT.pdf

3832-KOLNP-2006-FORM 1-1.1.pdf

3832-KOLNP-2006-FORM 1-1.2.pdf

3832-kolnp-2006-form 18.pdf

3832-KOLNP-2006-FORM 2-1.1.pdf

3832-KOLNP-2006-FORM 2.pdf

3832-KOLNP-2006-FORM 3-1.1.pdf

3832-KOLNP-2006-FORM 3-1.2.pdf

3832-KOLNP-2006-GPA.pdf

3832-KOLNP-2006-GRANTED-ABSTRACT.pdf

3832-KOLNP-2006-GRANTED-CLAIMS.pdf

3832-KOLNP-2006-GRANTED-DESCRIPTION (COMPLETE).pdf

3832-KOLNP-2006-GRANTED-DRAWINGS.pdf

3832-KOLNP-2006-GRANTED-FORM 1.pdf

3832-KOLNP-2006-GRANTED-FORM 2.pdf

3832-KOLNP-2006-GRANTED-FORM 3.pdf

3832-KOLNP-2006-GRANTED-FORM 5.pdf

3832-KOLNP-2006-GRANTED-SPECIFICATION-COMPLETE.pdf

3832-KOLNP-2006-INTERNATIONAL PUBLICATION.pdf

3832-KOLNP-2006-INTERNATIONAL SEARCH REPORT & OTHERS.pdf

3832-KOLNP-2006-OTHERS-1.1.pdf

3832-KOLNP-2006-OTHERS.pdf

3832-KOLNP-2006-PETITION UNDER RULE 137-1.1.pdf

3832-KOLNP-2006-PETITION UNDER RULE 137.pdf

3832-KOLNP-2006-REPLY TO EXAMINATION REPORT.pdf


Patent Number 256445
Indian Patent Application Number 3832/KOLNP/2006
PG Journal Number 25/2013
Publication Date 21-Jun-2013
Grant Date 17-Jun-2013
Date of Filing 19-Dec-2006
Name of Patentee COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Applicant Address LIMESTONE AVENUE, CAMPBELL, ACT 2601, AUSTRALIA
Inventors:
# Inventor's Name Inventor's Address
1 MCNALLY,MICHAEL 6 SUZANNE CLOSE,BEROWRA HEIGHTS,NSW 2082,AUSTRALIA
2 HORSHAM, MARK, ANDREW 5 ALOHA STREET,MASCOT,NSW 2020,AUSTRALIA
3 MURPHY,JAMES,KEITH,GERARD 43 GOODEN DRIVE,BAULKHAM HILLS,NSW 2153,AUSTRALIA
4 SANTANGELO,ROSS,ANTHONY 6 MACNAMARA AVENUE,CONCORD,NSW 2137,AUSTRALIA
5 SCULLY,ANDREW,DAVID 28 SANTA ROSA AVENUE,RYDE,NSW 2112,AUSTRALIA
PCT International Classification Number C09K 15/08
PCT International Application Number PCT/AU2005/000941
PCT International Filing date 2005-06-28
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 2004903522 2004-06-28 Australia